keyword
MENU ▼
Read by QxMD icon Read
search

HHS

keyword
https://www.readbyqxmd.com/read/29141630/ct-based-analysis-of-muscle-volume-and-degeneration-of-gluteus-medius-in-patients-with-unilateral-hip-osteoarthritis
#1
Takako Momose, Yutaka Inaba, Hyonmin Choe, Naomi Kobayashi, Taro Tezuka, Tomoyuki Saito
BACKGROUND: The gluteus medius (GMED) affects hip function as an abductor. We evaluated muscle volume and degeneration of the GMED by using CT-based analysis and assessed factors that affect hip abductor strength in patients with unilateral hip osteoarthritis (OA). METHODS: We examined clinical and imaging findings associated with hip abductor strength in consecutive 50 patients with unilateral hip OA. Hip abductor muscle strength and Harris hip score (HHS) were assessed...
November 15, 2017: BMC Musculoskeletal Disorders
https://www.readbyqxmd.com/read/29141357/-prevention-for-glucocorticoid-induced-osteonecrosis-of-femoral-head-a-long-term-clinical-follow-up-trail
#2
B Y Liu, L Yang, B J Wang, Z H Wang, L L Cheng, H Xie, X Qiu, Z J Ma, D W Zhao
Objective: To evaluated the outcome of prevention and treatment for glucocorticoid-induced osteonecrosis of femoral head with anticoagulant and vasodilator drugs. Methods: A prospective, randomized, double-blind study was performed. From August 2003 to August 2006, 58 patients with large amounts of hormone therapy in the Zhongshan Hospital Affiliated Dalian University were enrolled and randomly assigned to the control group (placebo) or preventive group (anticoagulant and vasodilator drugs). And we prospectively analyzed the clinical outcomes of 24 patients with glucocorticoid-induced osteonecrosis of femoral head early stage (treatment group)treated by anticoagulant and vasodilator drugsat the same time...
November 7, 2017: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://www.readbyqxmd.com/read/29137295/clinical-outcome-of-dynamic-hip-locking-plates-and-proximal-femoral-nails-anti-rotation-asia-for-treating-intertrochanteric-femur-fracture-with-lateral-wall-fractures-in-the-elder-patients
#3
Hui Xie, Zhan Wang, Junji Zhang, Langhai Xu, Bao Chen
Purpose: To compare the clinical results of DHLP (Dynamic hip locking plates) and PFNA-IIs (proximal femoral nails anti-rotation-Asia) for treating intertrochanteric femur fracture (IFF) with lateral wall fractures in the elder patients and provide a rationale for the clinical practice. Methods: A retrospective analysis of 43 patients of IFF with lateral wall fractures was performed from December 2009 to April 2015. Intraoperative variables and postoperative complications and function were compared between the two groups...
October 10, 2017: Oncotarget
https://www.readbyqxmd.com/read/29118279/measuring-the-impact-of-cultural-competence-training-for-dental-hygiene-students
#4
Heather N Daugherty, Rachel C Kearney
Purpose: The purpose of this study was to measure the change in levels of knowledge of providing culturally competent care and self-assessed cultural competence of senior level dental hygiene students after the implementation of an online cultural competence training module.Methods: Twenty-eight members of the senior class of 31 dental hygiene students (N=28) volunteered to participate in this IRB approved study at the Ohio State University School of Dentistry. The students took the online Inventory for Assessing the Process of Cultural Competence- Student Version (IAPCC-SV), to assess their self-perceived cultural competence...
October 2017: Journal of Dental Hygiene: JDH
https://www.readbyqxmd.com/read/29117365/pediatric-exclusivity-and-regulatory-authority-implications-of-amgen-v-hhs
#5
Jeanie Kim, Joseph S Ross, Amy Kapczynski
No abstract text is available yet for this article.
November 8, 2017: JAMA: the Journal of the American Medical Association
https://www.readbyqxmd.com/read/29111624/medicare-and-medicaid-programs-cy-2018-home-health-prospective-payment-system-rate-update-and-cy-2019-case-mix-adjustment-methodology-refinements-home-health-value-based-purchasing-model-and-home-health-quality-reporting-requirements-final-rule
#6
(no author information available yet)
This final rule updates the home health prospective payment system (HH PPS) payment rates, including the national, standardized 60-day episode payment rates, the national per-visit rates, and the non-routine medical supply (NRS) conversion factor, effective for home health episodes of care ending on or after January 1, 2018. This rule also: Updates the HH PPS case-mix weights using the most current, complete data available at the time of rulemaking; implements the third year of a 3-year phase-in of a reduction to the national, standardized 60-day episode payment to account for estimated case-mix growth unrelated to increases in patient acuity (that is, nominal case-mix growth) between calendar year (CY) 2012 and CY 2014; and discusses our efforts to monitor the potential impacts of the rebasing adjustments that were implemented in CY 2014 through CY 2017...
November 7, 2017: Federal Register
https://www.readbyqxmd.com/read/29111623/medical-devices-exemption-from-premarket-notification-class-ii-devices-autosomal-recessive-carrier-screening-gene-mutation-detection-system-final-order
#7
(no author information available yet)
The Food and Drug Administration (FDA or Agency) is publishing an order to exempt autosomal recessive carrier screening gene mutation detection systems from the premarket notification requirements, subject to certain limitations. This exemption from 510(k), subject to certain limitations, is immediately in effect for autosomal recessive carrier screening gene mutation detection systems. This exemption will decrease regulatory burdens on the medical device industry and will eliminate private costs and expenditures required to comply with certain Federal regulations...
November 7, 2017: Federal Register
https://www.readbyqxmd.com/read/29111622/medical-devices-immunology-and-microbiology-devices-classification-of-the-genetic-health-risk-assessment-system-final-order
#8
(no author information available yet)
The Food and Drug Administration (FDA, the Agency, or we) is classifying the genetic health risk assessment system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the genetic health risk assessment system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device...
November 7, 2017: Federal Register
https://www.readbyqxmd.com/read/29111621/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-total-25-hydroxyvitamin-d-mass-spectrometry-test-system-final-order
#9
(no author information available yet)
The Food and Drug Administration (FDA, the Agency, or we) is classifying the total 25-hydroxyvitamin D mass spectrometry test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the total 25-hydroxyvitamin D mass spectrometry test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device...
November 7, 2017: Federal Register
https://www.readbyqxmd.com/read/29109609/end-stage-renal-disease-increases-rates-of-adverse-glucose-events-when-treating-diabetic-ketoacidosis-or-hyperosmolar-hyperglycemic-state
#10
Caitlin M Schaapveld-Davis, Ana L Negrete, Joanna Q Hudson, Jagannath Saikumar, Christopher K Finch, Mehmet Kocak, Pan Hu, Megan A Van Berkel
IN BRIEF Treatment guidelines for diabetic emergencies are well described in patients with normal to moderately impaired kidney function. However, management of patients with end-stage renal disease (ESRD) is an ongoing challenge. This article describes a retrospective study comparing the rates of adverse glucose events (defined as hypoglycemia or a decrease in glucose >200 mg/dL/h) between patients with ESRD and those with normal kidney function who were admitted with diabetic ketoacidosis (DKA) or hyperosmolar hyperglycemic state (HHS)...
October 2017: Clinical Diabetes: a Publication of the American Diabetes Association
https://www.readbyqxmd.com/read/29107099/expression-and-characterization-of-a-novel-chitinase-with-antifungal-activity-from-a-rare-actinomycete-saccharothrix-yanglingensis-hhs-015
#11
Youyou Lu, Nana Wang, Jiao He, Yanfang Li, Xiaoning Gao, Lili Huang, Xia Yan
Saccharothrix yanglingensis Hhs.015, a new type of rare actinomycete, was isolated from the roots of cucumber. A novel chitinase gene was cloned from S. yanglingensis Hhs.015 and overexpressed as a soluble protein Chi6769 (77.9 kDa) in Escherichia coli. Chi6769 was purified by HisTrap HP affinity chromatography with optimal pH of 7.0. The enzymatic hydrolysis assay revealed that Chi6769 was capable of hydrolyzing chitin to (GlcNAc)3, (GlcNAc)2 and GlcNAc. (GlcNAc)2 was the main hydrolyzate. The antifungal activity result showed that Chi6769 exhibited strong antifungal activity toward Valsa mali 03-8...
November 1, 2017: Protein Expression and Purification
https://www.readbyqxmd.com/read/29106948/good-functional-outcome-but-not-regained-health-related-quality-of-life-in-the-majority-of-20-69-years-old-patients-with-femoral-neck-fracture-treated-with-internal-fixation-a-prospective-2-year-follow-up-study-of-182-patients
#12
Pierre Campenfeldt, Margareta Hedström, Wilhelmina Ekström, Amer N Al-Ani
BACKGROUND AND PURPOSE: Prospective studies on patient related outcome in patients <70years with a femoral neck fracture (FNF) are few. We aimed to investigate functional outcome and health-related quality of life (HRQoL) in 20-69years old patients with a FNF treated with internal fixation. PATIENTS AND METHODS: 182 patients, 20-69years with a FNF treated with internal fixation were prospectively included in a multicenter study. Follow up included radiographic and clinical examination at 4, 12 and 24 months...
October 18, 2017: Injury
https://www.readbyqxmd.com/read/29098380/bone-morphogenic-protein-2-use-in-revision-total-hip-arthroplasty-with-acetabular-defects
#13
Scott R Nodzo, Keely K Boyle, Sonja Pavlesen, Sridhar Rachala
INTRODUCTION: The restoration of acetabular bone stock during revision hip arthroplasty remains a challenge. There have been no clinical series reporting the efficacy of bone morphogenic protein-2 (rhBMP-2) in the revision hip setting. METHODS: We retrospectively reviewed the radiographs and records of 15 patients who received rhBMP-2 mixed with allograft bone chips (+BMP), and 14 who received allograft bone chips alone (-BMP) for their acetabular defect during revision total hip arthroplasty with a mean two-year follow up...
November 3, 2017: International Orthopaedics
https://www.readbyqxmd.com/read/29096971/no-correlation-between-press-ganey-survey-responses-and-outcomes-in-post-total-hip-arthroplasty-patients
#14
Morad Chughtai, Chukwuweike U Gwam, Anton Khlopas, Nipun Sodhi, Ronald E Delanois, Kurt P Spindler, Michael A Mont
BACKGROUND: In the era of the online orthopedic market, patients tend to equate publicly available online satisfaction surveys with what they presume their ultimate surgical outcome will be. Therefore, the purpose of this study was to assess whether there is a correlation between Press Ganey (PG) scores and (1) Hip Western Ontario and McMaster Universities Osteoarthritis Index and Harris Hip Score; (2) Short Form-12 and Short Form-36 scores; (3) University of California Los Angeles and Visual Analog Scale scores assessed at a mean of 3 years (range, 1 to 6 years) after surgery...
October 6, 2017: Journal of Arthroplasty
https://www.readbyqxmd.com/read/29091373/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis-services-furnished-to-individuals-with-acute-kidney-injury-and-end-stage-renal-disease-quality-incentive-program-final-rule
#15
(no author information available yet)
This rule updates and makes revisions to the end-stage renal disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2018. It also updates the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). This rule also sets forth requirements for the ESRD Quality Incentive Program (QIP), including for payment years (PYs) 2019 through 2021.
November 1, 2017: Federal Register
https://www.readbyqxmd.com/read/29091372/medical-devices-immunology-and-microbiology-devices-classification-of-the-bcr%C3%A2-abl-quantitation-test-final-order
#16
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the BCR-ABL quantitation test into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the BCR-ABL quantitation test's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens...
November 1, 2017: Federal Register
https://www.readbyqxmd.com/read/29091371/medical-devices-immunology-and-microbiology-devices-classification-of-the-newborn-screening-test-for-severe-combined-immunodeficiency-disorder-final-order
#17
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the newborn screening test for severe combined immunodeficiency disorder (SCID) into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the newborn screening test for SCID's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device...
October 30, 2017: Federal Register
https://www.readbyqxmd.com/read/29091370/medical-devices-immunology-and-microbiology-devices-classification-of-the-aquaporin-4-autoantibody-immunological-test-system-final-order
#18
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the Aquaporin-4 autoantibody immunological test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the Aquaporin-4 autoantibody immunological test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device...
October 30, 2017: Federal Register
https://www.readbyqxmd.com/read/29091369/medical-devices-immunology-and-microbiology-devices-classification-of-the-streptococcus-spp-nucleic-acid-based-assay-final-order
#19
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the Streptococcus spp. nucleic acid-based assay into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the Streptococcus spp. nucleic acid-based assay's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device...
October 30, 2017: Federal Register
https://www.readbyqxmd.com/read/29091368/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-acute-kidney-injury-test-system-final-order
#20
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the acute kidney injury test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the acute kidney injury test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens...
October 30, 2017: Federal Register
keyword
keyword
43624
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"